IBBQ:NSD-Invesco Nasdaq Biotechnology ETF (USD)

ETF | Others |

Last Closing

USD 22.18

Change

0.00 (0.00)%

Market Cap

USD 0.04B

Volume

1.90K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

+2.48 (+5.20%)

USD 50.95B
QQQM Invesco NASDAQ 100 ETF

+3.87 (+1.95%)

USD 39.48B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.96 (+1.82%)

USD 22.06B
ACWI iShares MSCI ACWI ETF

+1.73 (+1.47%)

USD 18.95B
CGABL The Carlyle Group Inc. 4.625% ..

-0.07 (-0.39%)

USD 16.14B
SNDK Sandisk Corp

-0.97 (-1.80%)

USD 5.99B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.01 (+0.01%)

USD 5.17B
NVDL GraniteShares 1.5x Long NVDA D..

+2.66 (+6.03%)

USD 3.76B
TSLL Direxion Shares ETF Trust - Di..

+2.12 (+23.45%)

USD 3.11B
ETHA iShares Ethereum Trust ETF

+0.90 (+6.03%)

USD 2.37B

ETFs Containing IBBQ

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.07% 78% C+ 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.07% 78% C+ 74% C
Trailing 12 Months  
Capital Gain 1.19% 54% F 58% F
Dividend Return 0.64% 21% F 13% F
Total Return 1.82% 40% F 54% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.56% 45% F 41% F
Dividend Return 0.91% 39% F 37% F
Total Return 0.35% 25% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 11.87% 49% F 87% B+
Risk Adjusted Return 7.66% 35% F 40% F
Market Capitalization 0.04B 55% F 27% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.